HALIFAX, April 2 /CNW/ - MedMira Inc., (“MedMira”) (TSX Venture: MIR, NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions, announced today that it is now an approved supplier to the Pan American Health Organization (PAHO) and has received an initial purchase order for rapid HIV tests from the Ministry of Health in Belize. The PAHO, headquartered in Washington, D.C., with 35 member states, is an international public health agency working with Latin America and Caribbean countries on priority health issues such as HIV. It also serves as the regional office for the World Health Organization (WHO) in the Americas.
